The APAC lyophilized injectable market is expected to grow from US$ 673.33 million in 2022 to US$ 996.85 million by 2028. It is estimated to grow at a CAGR of 6.8% from 2022 to 2028.
Advancement in Lyophilized Packaging
The complexity of drug reconstitution constrained the market potential for lyophilized drugs and vaccines. Multiple pieces of device and long procedures are required to reconstitute a lyophilized drug from a vial; thus, most of these products are restricted within healthcare facilities. However, the healthcare transformation toward patient self-injection and the acceleration after biologics flared a new wave of creation for drug reconstitution technology. Dual-chamber syringes represent an enabling technology for the self-injection of lyophilized drugs and new therapies directing the mixing of two liquid molecules at the time of drug delivery. Prefilled dual chamber devices (DCDs) are combination devices containing freeze-dried drugs and diluent in two separate chambers of the device. DCDs have shown many advantages, such as easy handling, accurate dosing, seal integrity, and high stability, compared to the traditional drug-delivery systems; therefore, they are promising alternatives to these traditional drug-delivery systems. DCDs are being increasingly preferred by physicians for patients needing instant relief and safe delivery, significantly improving drug delivery by quickly applying pressure to the end plunger after mixing and dissolving freeze-dried powder. DCDs can improve long-term pharmaceutical stability by storing them in the lyophilized form before administration and therefore are becoming more popular, especially for those unstable pharmaceutical products. Therefore, advancement in lyophilized packaging is expected to drive the market across the region.Market Overview
The APAC lyophilized injectable market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. China dominated the market in 2022. The market's growth is primarily attributed to the established pharmaceutical market, increased R&D expenditures by pharmaceutical and biopharmaceutical companies, and favorable regulatory policies. The excessive population in China and the rise of various communicable and noncommunicable diseases are majorly driving the pharmaceutical companies in China, making it a prime market in Asia Pacific. For instance, the COVID-19 outbreak in China led to the launch of several drugs to counter the virus. It increased contract manufacturing of drugs, such as lyophilized remdesivir powder, fueling the demand for lyophilized injectables in the country. Due to the pandemic, various market players ramped up the production of certain lyophilized drugs as it ensures safe and prolonged packaging of the drugs. Market players in China have constantly been evolving with organic and inorganic strategies. For instance, WuXi STA; a subsidiary of WuXi AppTec; announced its first parenteral formulation production line at the Wuxi city site. This wholly automatic sterile manufacturing line runs in a complete isolation system with an annual capacity of 2 million units. The automatic parenteral filling line features numerous filling modules and a built-in lyophilizer to fill syringes, vials, and cartridges of a full range of sizes and produce lyophilized powders. Thus, growing pharmaceutical & biopharmaceutical market and increasing initiatives by market players are expected to drive the market during the forecast period.APAC Lyophilized Injectable Market Segmentation
The APAC lyophilized injectable market is segmented based on type of packaging, type of delivery, indication, end user, and country.- Based on type of packaging, the APAC lyophilized injectable market is segmented into single-use vials, point-of-care reconstitution, and specialty packaging. The single-use vials segment held the largest market share in 2022.
- Based on indication, the APAC lyophilized injectable market is segmented into metabolic and oncology conditions, infectious diseases, autoimmune diseases, and others. The metabolic and oncology conditions segment held the largest market share in 2022.
- Based on end user, the APAC lyophilized injectable market is categorized into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospitals segment held the largest market share in 2022.
- Based on country, the APAC lyophilized injectable market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. China dominated the market in 2022.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Lyophilized Injectable Market - By Type of Packaging
1.3.2 APAC Lyophilized Injectable Market - By Type of Delivery
1.3.3 APAC Lyophilized Injectable Market - By Indication
1.3.4 APAC Lyophilized Injectable Market - By End User
1.3.5 APAC Lyophilized Injectable Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Lyophilized Injectable Market - Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Lyophilized Injectable Market- Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Demand for Contract Research Manufacturing Services
5.1.2 Increasing Demand of Biologics
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Expansion of Pipeline of Lyophilized Injectable Drugs
5.4 Future Trends
5.4.1 Advancement in Lyophilized Packaging
5.5 Impact Analysis
6. Lyophilized Injectable Market- APAC Analysis
6.1 APAC Lyophilized Injectable Market Revenue Forecast and Analysis
7. APAC Lyophilized Injectable Market Analysis - By Type of Packaging
7.1 Overview
7.2 APAC Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
7.3 Single-use vials
7.3.1 Overview
7.3.2 Single-use vials: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Point-of-Care Reconstitution
7.4.1 Overview
7.4.2 Point-of-Care Reconstitution: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Specialty Packaging
7.5.1 Overview
7.5.2 Specialty Packaging: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8. APAC Lyophilized Injectable Market Analysis - By Type of Delivery
8.1 Overview
8.2 APAC Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
8.3 Prefilled Diluent Syringes
8.3.1 Overview
8.3.2 Prefilled Diluent Syringes: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Single Step Devices
8.4.1 Overview
8.4.2 Single Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Proprietary Reconstitution Devices
8.5.1 Overview
8.5.2 Proprietary Reconstitution Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Multi-Step Devices
8.6.1 Overview
8.6.2 Multi-Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9. APAC Lyophilized Injectable Market Analysis - By Indication
9.1 Overview
9.2 APAC Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
9.3 Metabolic and Oncology Conditions
9.3.1 Overview
9.3.2 Metabolic and Oncology Conditions: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Infectious Diseases
9.4.1 Overview
9.4.2 Infectious Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Autoimmune Diseases
9.5.1 Overview
9.5.2 Autoimmune Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Other Indications
9.6.1 Overview
9.6.2 Other Indications: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10. APAC Lyophilized Injectable Market Analysis - By End User
10.1 Overview
10.2 APAC Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Specialty Clinics
10.5.1 Overview
10.5.2 Specialty Clinics: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Other End Users
10.6.1 Overview
10.6.2 Other End Users: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
11. APAC Lyophilized Injectable Market - Country Analysis
11.1 Overview
11.1.1 APAC: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
11.1.1.1 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.1.3 China: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
11.1.1.1.4 China: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
11.1.1.1.5 China: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
11.1.1.1.6 China: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
11.1.1.2 India Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 India: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.2.3 India: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
11.1.1.2.4 India: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
11.1.1.2.5 India: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
11.1.1.2.6 India: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
11.1.1.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.3.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
11.1.1.3.4 Japan: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
11.1.1.3.5 Japan: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
11.1.1.3.6 Japan: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
11.1.1.4 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.4.3 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
11.1.1.4.4 South Korea: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
11.1.1.4.5 South Korea: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
11.1.1.4.6 South Korea: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
11.1.1.5 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.5.1 Overview
11.1.1.5.2 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.5.3 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
11.1.1.5.4 Australia: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
11.1.1.5.5 Australia: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
11.1.1.5.6 Australia: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
11.1.1.6 Rest of APAC: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of APAC: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.3 Rest of APAC: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
11.1.1.6.4 Rest of APAC: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
11.1.1.6.5 Rest of APAC: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
11.1.1.6.6 Rest of APAC: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
12. Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Baxter
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Nipro
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Curia Global, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Recipharm AB
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Vetter Pharma
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Jubilant HollisterStier (Jubilant Pharma Limited)
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Aristopharma Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 CordenPharma International
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Credence MedSystems, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 S.G. Biopharm Pvt. Ltd.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
List of Tables
Table 1. APAC Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. China: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
Table 3. China: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 4. China: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 5. China: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 6. India: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
Table 7. India: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 8. India: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 9. India: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 10. Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
Table 11. Japan: Lyophilized Injectable Market, by Type of Delivery- Revenue and Forecast to 2028 (US$ Million)
Table 12. Japan: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 13. Japan: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
Table 15. South Korea: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 16. South Korea: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 17. South Korea: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 18. Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
Table 19. Australia: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 20. Australia: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 21. Australia: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of APAC: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
Table 23. Rest of APAC: Lyophilized Injectable Market, by Type of Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of APAC: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of APAC: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 26. Recent Inorganic Growth Strategies
Table 27. Recent Organic Growth Strategies
Table 28. Glossary of Terms
List of Figures
Figure 1. APAC Lyophilized Injectable Market Segmentation
Figure 2. APAC Lyophilized Injectable Market - By Country
Figure 3. APAC Lyophilized Injectable Market Overview
Figure 4. APAC Lyophilized Injectable Market, By Type of Packaging
Figure 5. APAC Lyophilized Injectable Market, By Country
Figure 6. APAC: PEST Analysis
Figure 7. Experts Opinion
Figure 8. APAC Lyophilized Injectable Market Impact Analysis of Drivers and Restraints
Figure 9. APAC Lyophilized Injectable Market- Revenue Forecast and Analysis
Figure 10. APAC Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
Figure 11. APAC Single-use vials: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. APAC Point-of-Care Reconstitution: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. APAC Specialty Packaging: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. APAC Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
Figure 15. APAC Prefilled Diluent Syringes: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. APAC Single Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. APAC Proprietary Reconstitution Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. APAC Multi-Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. APAC Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
Figure 20. APAC Metabolic and Oncology Conditions: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. APAC Infectious Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. APAC Autoimmune Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. APAC Other Indications: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. APAC Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
Figure 25. APAC Hospitals: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. APAC Ambulatory Surgical Centers: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. APAC Specialty Clinics: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. APAC Other End Users: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. APAC Lyophilized Injectable Market Overview, by Country (2021)
Figure 30. APAC: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
Figure 31. China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. India: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Rest of APAC: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aristopharma Ltd.
- Baxter
- CordenPharma International
- Credence MedSystems, Inc.
- Curia Global, Inc.
- Jubilant HollisterStier (Jubilant Pharma Limited)
- Nipro
- Recipharm AB
- S.G. Biopharm Pvt. Ltd.
- Vetter Pharma
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 141 |
| Published | December 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 673.33 Million |
| Forecasted Market Value ( USD | $ 996.85 Million |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Asia Pacific |
